Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy

Ann Intern Med. 2006 Aug 1;145(3):234-5. doi: 10.7326/0003-4819-145-3-200608010-00021.
No abstract available

Publication types

  • Letter

MeSH terms

  • Erythropoietin / administration & dosage
  • Erythropoietin / adverse effects*
  • Fibrosis / etiology
  • Humans
  • Recombinant Proteins
  • Renal Insufficiency / complications*
  • Skin Diseases / etiology*
  • Skin Diseases / pathology*

Substances

  • Recombinant Proteins
  • Erythropoietin